Is Novartis still a player to buy out CTIC if Pixantrone is approved? I thought Novartis could buy it for approx $120M. If so, what happens to CTIC and any stock increase?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.